Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results

Sientra Reports Preliminary Fourth Quarter and Full Year 2020 Results
Estimates highest ever Breast Products segment net sales of $17.9 million, representing 40% year over year growth
Results driven by Sientra’s continued investment and market outperformance in the core breast products segment
SANTA BARBARA, Calif., Feb. 04, 2021 — Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company uniquely focused on plastic surgeons, today announced its preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2020.
Ron Menezes, President and Chief Executive Officer of Sientra, stated, “As the only breast aesthetics company committed exclusively to the plastic surgery channel, Sientra is focused on becoming the leader in novel treatments that progress the art of plastic surgery. Throughout 2020, Sientra increased investment in our breast aesthetics business, expanding our salesforce and production capacity, and launching strategic marketing programs tailored to the plastic surgery community to effectively drive new patients to their practices. We believe the results of our disciplined focus and execution are validated by our performance in Q4 2020, nearly doubling the year-over-year growth reported in Q3 2020. Importantly, this performance has provided strong momentum as we head into 2021, with these revenue trends continuing into Q1 2021 to date. Our 2021 strategy emphasizes our continued marketing focus to increase awareness of the Sientra brand among both women and surgeons. This campaign is designed to gain market share in private practices and hospitals, as well as drive home our scientific advantage and value to plastic surgeons.

Related Keywords

California , United States , Japan , Ron Menezes , Santa Barbara , Exchange Commission , Securities Exchange , Sientra Inc , Company Breast Products Segment , Nasdaq , Breast Products , Chief Executive Officer , Full Year , Sientra Gel Sizer , Saline Sizer , Breast Products Segment , Dry Segment , Securities Act , Securities Exchange Act , Risk Factors , Investor Relations , கலிஃபோர்னியா , ஒன்றுபட்டது மாநிலங்களில் , ஜப்பான் , ரோன் மெனிசஸ் , சாந்தா பார்பரா , பரிமாற்றம் தரகு , பத்திரங்கள் பரிமாற்றம் , நிறுவனம் மார்பக ப்ராடக்ட்ஸ் பிரிவு , நாஸ்டாக் , மார்பக ப்ராடக்ட்ஸ் , தலைமை நிர்வாகி அதிகாரி , முழு ஆண்டு , உப்பு சைசர் , மார்பக ப்ராடக்ட்ஸ் பிரிவு , உலர்ந்த பிரிவு , பத்திரங்கள் நாடகம் , பத்திரங்கள் பரிமாற்றம் நாடகம் , ஆபத்து காரணிகள் , முதலீட்டாளர் உறவுகள் ,